Selected article for: "clinical form and severe clinical form"

Author: Colafrancesco, Serena; Alessandri, Cristiano; Conti, Fabrizio; Priori, Roberta
Title: COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
  • Cord-id: v7wgb6mr
  • Document date: 2020_5_5
  • ID: v7wgb6mr
    Snippet: The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term “hyperferritinemic syndrome” and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and “hyperferritinemic syndromes” are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm
    Document: The severe form of COVID-19 share several clinical and laboratory features with four entities gathered under the term “hyperferritinemic syndrome” and including macrophage activation syndrome (MAS), adult-onset Still's disease (AOSD), catastrophic anti-phospholipid syndrome (CAPS) and septic shock. COVID-19 systemic inflammatory reaction and “hyperferritinemic syndromes” are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. In this review, we analyze the possible epidemiological and molecular mechanisms responsible for hyper-inflammation in patients with severe COVID-19 and we underline the similarities between this condition and “hyperferritinemic syndromes” which would allow considering this entity as the fifth member of the spectrum of inflammatory conditions.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver and acute phase response: 1
    • abnormal liver and adaptive innate: 1
    • abnormal liver and low molecular weight heparin: 1
    • abnormal liver and lung consolidation: 1
    • abnormal liver and macrophage activation: 1, 2
    • abnormal liver and macrophage activation syndrome: 1, 2
    • abnormal liver and macrophage monocyte: 1
    • abnormal liver function and acute phase response: 1
    • abnormal liver function and macrophage activation: 1
    • abnormal liver function and macrophage activation syndrome: 1